vs

Side-by-side financial comparison of Harmony Biosciences Holdings, Inc. (HRMY) and InterDigital, Inc. (IDCC). Click either name above to swap in a different company.

Harmony Biosciences Holdings, Inc. is the larger business by last-quarter revenue ($243.8M vs $205.4M, roughly 1.2× InterDigital, Inc.). InterDigital, Inc. runs the higher net margin — 36.7% vs 9.2%, a 27.4% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs -2.4%). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs -4.1%).

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

InterDigital, Inc. is an American technology research and development company that provides wireless and video technologies for mobile devices, networks, and services worldwide. Founded in 1972, InterDigital is listed on the Nasdaq and is included in the S&P 600 index.

HRMY vs IDCC — Head-to-Head

Bigger by revenue
HRMY
HRMY
1.2× larger
HRMY
$243.8M
$205.4M
IDCC
Growing faster (revenue YoY)
HRMY
HRMY
+23.5% gap
HRMY
21.1%
-2.4%
IDCC
Higher net margin
IDCC
IDCC
27.4% more per $
IDCC
36.7%
9.2%
HRMY
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
-4.1%
IDCC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HRMY
HRMY
IDCC
IDCC
Revenue
$243.8M
$205.4M
Net Profit
$22.5M
$75.3M
Gross Margin
71.9%
Operating Margin
15.8%
40.0%
Net Margin
9.2%
36.7%
Revenue YoY
21.1%
-2.4%
Net Profit YoY
-54.6%
-34.8%
EPS (diluted)
$0.38
$2.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRMY
HRMY
IDCC
IDCC
Q1 26
$205.4M
Q4 25
$243.8M
$158.2M
Q3 25
$239.5M
$164.7M
Q2 25
$200.5M
$300.6M
Q1 25
$184.7M
$210.5M
Q4 24
$201.3M
$252.8M
Q3 24
$186.0M
$128.7M
Q2 24
$172.8M
$223.5M
Net Profit
HRMY
HRMY
IDCC
IDCC
Q1 26
$75.3M
Q4 25
$22.5M
$43.0M
Q3 25
$50.9M
$67.5M
Q2 25
$39.8M
$180.6M
Q1 25
$45.6M
$115.6M
Q4 24
$49.5M
$133.1M
Q3 24
$46.1M
$34.2M
Q2 24
$11.6M
$109.7M
Gross Margin
HRMY
HRMY
IDCC
IDCC
Q1 26
Q4 25
71.9%
Q3 25
75.1%
Q2 25
81.0%
Q1 25
82.7%
Q4 24
73.0%
Q3 24
77.0%
Q2 24
81.4%
Operating Margin
HRMY
HRMY
IDCC
IDCC
Q1 26
40.0%
Q4 25
15.8%
30.2%
Q3 25
27.3%
46.0%
Q2 25
24.0%
68.3%
Q1 25
30.4%
62.6%
Q4 24
27.7%
64.3%
Q3 24
33.2%
30.6%
Q2 24
12.4%
59.9%
Net Margin
HRMY
HRMY
IDCC
IDCC
Q1 26
36.7%
Q4 25
9.2%
27.2%
Q3 25
21.2%
41.0%
Q2 25
19.8%
60.1%
Q1 25
24.7%
54.9%
Q4 24
24.6%
52.7%
Q3 24
24.8%
26.6%
Q2 24
6.7%
49.1%
EPS (diluted)
HRMY
HRMY
IDCC
IDCC
Q1 26
$2.14
Q4 25
$0.38
$1.07
Q3 25
$0.87
$1.93
Q2 25
$0.68
$5.35
Q1 25
$0.78
$3.45
Q4 24
$0.85
$4.12
Q3 24
$0.79
$1.14
Q2 24
$0.20
$3.93

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRMY
HRMY
IDCC
IDCC
Cash + ST InvestmentsLiquidity on hand
$775.3M
Total DebtLower is stronger
$163.7M
$377.8M
Stockholders' EquityBook value
$870.2M
$1.1B
Total Assets
$1.3B
$2.1B
Debt / EquityLower = less leverage
0.19×
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRMY
HRMY
IDCC
IDCC
Q1 26
Q4 25
$775.3M
$1.2B
Q3 25
$672.6M
$1.3B
Q2 25
$565.3M
$937.0M
Q1 25
$507.0M
$883.3M
Q4 24
$467.2M
$958.2M
Q3 24
$410.5M
$813.2M
Q2 24
$346.9M
$760.3M
Total Debt
HRMY
HRMY
IDCC
IDCC
Q1 26
$377.8M
Q4 25
$163.7M
$16.3M
Q3 25
$168.5M
$17.1M
Q2 25
$172.1M
$16.6M
Q1 25
$175.7M
$16.0M
Q4 24
$179.3M
$15.4M
Q3 24
$182.8M
$18.3M
Q2 24
$186.4M
$17.7M
Stockholders' Equity
HRMY
HRMY
IDCC
IDCC
Q1 26
$1.1B
Q4 25
$870.2M
$1.1B
Q3 25
$835.1M
$1.1B
Q2 25
$773.1M
$1.1B
Q1 25
$720.5M
$936.9M
Q4 24
$659.2M
$857.2M
Q3 24
$596.8M
$722.5M
Q2 24
$538.6M
$696.8M
Total Assets
HRMY
HRMY
IDCC
IDCC
Q1 26
$2.1B
Q4 25
$1.3B
$2.1B
Q3 25
$1.2B
$2.1B
Q2 25
$1.1B
$2.0B
Q1 25
$1.1B
$1.9B
Q4 24
$999.2M
$1.8B
Q3 24
$928.1M
$1.7B
Q2 24
$858.4M
$1.6B
Debt / Equity
HRMY
HRMY
IDCC
IDCC
Q1 26
0.34×
Q4 25
0.19×
0.01×
Q3 25
0.20×
0.02×
Q2 25
0.22×
0.02×
Q1 25
0.24×
0.02×
Q4 24
0.27×
0.02×
Q3 24
0.31×
0.03×
Q2 24
0.35×
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRMY
HRMY
IDCC
IDCC
Operating Cash FlowLast quarter
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRMY
HRMY
IDCC
IDCC
Q1 26
Q4 25
$126.2M
$544.5M
Q3 25
$108.7M
$395.9M
Q2 25
$79.3M
$105.1M
Q1 25
$34.0M
$-20.0M
Q4 24
$75.6M
$271.5M
Q3 24
$70.5M
$77.6M
Q2 24
$42.6M
$-48.9M
Free Cash Flow
HRMY
HRMY
IDCC
IDCC
Q1 26
Q4 25
$126.0M
$528.6M
Q3 25
$108.7M
$395.3M
Q2 25
$79.3M
$104.5M
Q1 25
$33.9M
$-34.5M
Q4 24
$75.0M
$265.7M
Q3 24
$70.5M
$76.7M
Q2 24
$42.0M
$-49.5M
FCF Margin
HRMY
HRMY
IDCC
IDCC
Q1 26
Q4 25
51.7%
334.0%
Q3 25
45.4%
240.1%
Q2 25
39.6%
34.8%
Q1 25
18.3%
-16.4%
Q4 24
37.3%
105.1%
Q3 24
37.9%
59.6%
Q2 24
24.3%
-22.1%
Capex Intensity
HRMY
HRMY
IDCC
IDCC
Q1 26
Q4 25
0.0%
10.0%
Q3 25
0.0%
0.4%
Q2 25
0.0%
0.2%
Q1 25
0.1%
6.9%
Q4 24
0.3%
2.3%
Q3 24
0.0%
0.7%
Q2 24
0.4%
0.3%
Cash Conversion
HRMY
HRMY
IDCC
IDCC
Q1 26
Q4 25
5.61×
12.67×
Q3 25
2.14×
5.87×
Q2 25
1.99×
0.58×
Q1 25
0.75×
-0.17×
Q4 24
1.53×
2.04×
Q3 24
1.53×
2.27×
Q2 24
3.68×
-0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons